Keyphrases
Acute Lymphoblastic Leukemia
100%
Chromosome 6
100%
Forkhead Box O3 (FOXO3)
100%
PRDM1
100%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
83%
Forkhead Box O1 (FOXO1)
83%
Transcription Factor
33%
Tumor Suppressor Gene
33%
Pre-B Cells
33%
Leukemia
16%
ETV6-RUNX1
16%
TCF3-PBX1
16%
Overexpression
16%
Large Deletion
16%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
16%
Multiple Genes
16%
Cancer Drivers
16%
Glycolysis
16%
B Cell Development
16%
Protective Behavior
16%
Interferon Regulatory Factor 4 (IRF4)
16%
Gene Set
16%
Recurrent Deletions
16%
Glycolysis Inhibitors
16%
Chemokines
16%
C-X-C Chemokine Receptor Type 4 (CXCR4)
16%
Genomic Data
16%
CDNA Clone
16%
Human Malignancies
16%
Suppressed Growth
16%
Transcriptomic Data
16%
Cell Cycle Exit
16%
Selinexor
16%
CRISPR-Cas9 Screen
16%
Transcriptomic Changes
16%
Thioredoxin-interacting Protein (TXNIP)
16%
ID50
16%
Clone Tracking
16%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
Chromosome 6
100%
PRDM1
100%
FOXO1
71%
FOXO3
71%
Tumor Suppressor Gene
28%
Cell Cycle
28%
Transcriptomics
28%
ETV6
14%
PBX1
14%
RUNX1
14%
TCF3
14%
CRISPR/Cas9
14%
Transcription Factors
14%
CRISPR
14%
Agonist
14%
IRF4
14%
Cell Maturation
14%
Chemokine
14%
CXCR4
14%
Low Drug Dose
14%
Molecular Cloning
14%
TXNIP
14%
Transcription Factor FKHRL1
14%
ID50
14%
Genomics
14%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Acute B-Cell Lymphoblastic Leukemia
100%
Chromosome 6
100%
Tumor Suppressor Gene
40%
Clustered Regularly Interspaced Short Palindromic Repeat
40%
Transcriptomics
40%
Cell Cycle
40%
Malignant Neoplasm
20%
Cancer
20%
In Vitro
20%
B Cell
20%
Leukemia
20%
Transcription Factors
20%
Cas9
20%
Low Drug Dose
20%
Interferon Regulatory Factor 4
20%
B Cell Development
20%
Chemokine
20%
Complementary DNA
20%
Selinexor
20%
Transcription Factor FKHRL1
20%
Immunology and Microbiology
B Cell
100%
Chromosome 6
100%
Tumor Suppressor Gene
33%
Cell Cycle
33%
Transcriptomics
33%
Transcription Factors
16%
Clustered Regularly Interspaced Short Palindromic Repeat
16%
CRISPR/Cas9
16%
Agonist
16%
B Cell Development
16%
Chemokine
16%
CXCR4
16%
Molecular Cloning
16%
Interferon Regulatory Factor 4
16%
Low Drug Dose
16%
ID50
16%
Transcription Factor FKHRL1
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Tumor Suppressor Protein
33%
Malignant Neoplasm
16%
Leukemia
16%
Transcription Factors
16%
Chemokine
16%
Interferon Regulatory Factor 4
16%
Selinexor
16%
Complementary DNA
16%
Transcription Factor FKHRL1
16%